Publication
Article
BioPharm International
BioPharm International-06-15-2016Volume2016 ebook Issue 1
Pages: 18–21
Biomanufacturers Demand Higher Quality Standards in 2016
Author(s):
Biopharmaceutical manufacturers continue to put quality at the forefront of their relationships.
Quality considerations have always been vital to biotherapeutic developers and CMOs. Yet, in 2016, it seems that these considerations are taking on a new emphasis. One of the main industry trends seen this year-increased attention to continuous bioprocessing-is at least partly driven by the potential for improved product quality.
Download the
BioPharm International 2016 Outsourcing Resources eBook.
Articles in this issue
Contract Service Providers Gear Up to Develop Emerging Therapies
Biopharma Service Providers Address a Full Plate of Challenges
Dealing with Pharmaceutical Supply-Chain Complexities
Keeping it Simple: Collaborating for Success in Drug Delivery
Regulatory Reform in China: Implications for Global Biopharmaceutical Companies
Biomanufacturers Demand Higher Quality Standards in 2016
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Videos
Related Content
